Katherine Turk, MD

Assistant Professor of Neurology
Boston University School of Medicine

VA Boston Healthcare System (12C) 
150 S. Huntington Street
Boston, MA 02130

Medical School: Tufts University School of Medicine (2011)
Internship: Internal Medicine, University of Washington (2012)
Residency: Neurology, University of Washington (2015)
Fellowship: Cognitive and Behavioral Neurology, VA Boston Healthcare System/Boston University School of Medicine (2017)
Board Certifications: Neurology

Special Interests:

Dr. Turk sees Memory disorders patients at VA Boston and is the Director of the TBI/Polytrauma clinic at VA Boston. Additionally, she is the site director for Neurology resident education at VA Boston. Her research interests include investigations of potential biomarkers of Alzheimer’s disease and Chronic Traumatic Encecephalopathy. She has funding from the Alzheimer’s association for a project investigating event-related potentials as a biomarker of Alzheimer’s disease . She is developing a research program in TBI and neurodegenerative conditions related to TBI at VA Boston.


KW Turk, AA Elshaar, RG Deason, NC Heyworth, C Nagle, B Frustace, S Flannery, A Zumwalt and AE Budson. Late positive component event-related potential amplitude predicts long-term classroom-based learning. Journal of Cognitive Neuroscience, April 2017, In Press.

Turk KW and Budson AE. Chronic Traumatic Encephalopathy Review. Accepted Continuum. In Press, May 2018.

Turk, KW, Gosselin E, Palumbo R, Nagle C, Tat M and Budson AE. False Memories: the other side of forgetting. In preparation, August 2018.

Turk KW, Flanagan M, Josephson JR, Keene CD,  Jayadev S and Bird T. Psychosis in Spinocerebellar Ataxias: A case series and study of Tyrosine Hydroxylase in Substantia Nigra. The Cerebellum, 2018 August 17(2): 143-151.

Gallagher LG, Ilango S, Wundes A, Stobbe GA, Turk KW, MD, Franklin GM, Linet MS, Freedman DM, Alexander BH, and Harvey Checkoway H. Lifetime Exposure to Ultraviolet   Radiation and the Risk of Multiple Sclerosis in the U.S. Radiologic Technologists Cohort Study. In Press, Multiple Sclerosis Journal May 2018.

Turk KW and Budson AE. Dementia, In: The Brigham Intensive Review of Internal Medicine. Third Edition. 2016.

Turk, J.B. Leverenz. Cognitive Impairment in Parkinson’s Disease: Biomarkers, neuroimaging, and genetics will play a vital role in helping to understand the origins of Parkinson disease and treating cognitive impairment in patients with the disease. Federal Practitioner. 2014 Jun 31(S5); 20S-23S.

Obermeier B, Lovato L, Mentele R, Brück W, Forne I, Imhof A, Lottspeich F, Turk KW, Willis SN, Wekerle H, Hohlfeld R, Hafler DA, O’Connor KC, Dornmair K. Related B cell clones that populate CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin. J Neuroimmunol. 2011 Apr;233(1-2):245-8.

Ratai EM, Pilkenton SJ, Greco JB, Lentz MR, Bombardier JP, Turk KW, He J, Joo CG, Lee V,Westmoreland S, Halpern E, Lackner AA,González RG.In vivo proton magnetic resonance Spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci. 2009 Jun 22;10:63.

Ratai EM, Hancu I, Blezek DJ, Turk KW, Halpern E, González RG. Automatic repositioning of CSI grids  in longitudinal 1H MRS studies: impact on reproducibility of metaboliteconcentration measurements. Journal of Magnetic Resonance Imaging. Magn Reson Imaging. 2008 May;27(5):1188-93.

Rapp D, Turk K, Bales G, Cook S.  Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder.  Journal of Urology. 2006 Mar;175(3 Pt 1):1138-42.